Raytech Holding Ltd - Form 6-K Summary
Business Context and Reporting Period
This Form 6-K report covers the month of August 2026 for Raytech Holding Limited, a foreign private issuer. The filing primarily addresses significant changes in corporate governance, specifically the resignation of a director and the Chief Financial Officer (CFO), and the subsequent appointment of replacements.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a disclosure of corporate events rather than a financial statement.
Material Changes
- Resignations: On August 15, 2026, Mr. Shihua Li resigned as a director, Chairperson of the Audit Committee, and member of the Compensation and Nominating and Corporate Governance Committees. Concurrently, Ms. Yee Hing Wan resigned as Chief Financial Officer. Both confirmed their resignations were not due to disagreements with the Company.
- Appointments:
- Dr. Gen Zhao: Appointed as an independent director, Chairperson of the Audit Committee, and member of the Compensation and Nominating and Corporate Governance Committees. He is currently the CFO of Trenda Group Holdings Limited.
- Mr. Songbin Yang: Appointed as Chief Financial Officer. He previously served as CFO of GoFintech Quantum Innovation Limited (a parent company of a major shareholder) and as an independent director of HK.AI Capital Limited (a parent company of another major shareholder).
Compensation and Agreements
- Dr. Gen Zhao: Entitled to annual cash compensation of US$14,400, payable quarterly in arrears. An indemnification agreement was also executed.
- Mr. Songbin Yang: Entitled to an annual base salary of US$72,000, plus eligibility for a discretionary/performance-based bonus and other benefits. The employment agreement has an indefinite term starting August 15, 2026. An indemnification agreement was also executed.
Outlook, Risks, and Contingencies
The Board determined that Dr. Zhao satisfies independence requirements under Nasdaq Listing Rules and Rule 10A-3, despite his employer's ultimate beneficial owner being a shareholder of Raytech. The Board also confirmed Dr. Zhao qualifies as an "audit committee financial expert." No material transactions involving Dr. Zhao or Mr. Yang were disclosed for the preceding three years. The filing notes that the descriptions of the agreements are qualified by reference to the full text filed as Exhibits 10.1, 10.2, and 10.3.
Key Facts for Investor Verification
- Verify the independence status of Dr. Gen Zhao given his employer's relationship with a Raytech shareholder.
- Review the full text of the employment and director agreements (Exhibits 10.1, 10.2, 10.3) for termination clauses and bonus structures.
- Confirm the operational impact of the simultaneous departure of the Audit Committee Chair and the CFO.
- Assess the potential for conflicts of interest regarding Mr. Yang's prior roles at companies linked to Raytech's largest shareholders.